Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

Recently approved vaccines have already shown remarkable protection in limiting SARS-CoV-2 associated disease. However, immunologic mechanism(s) of protection, as well as how boosting alters immunity to wildtype and newly emerging strains, remain incompletely understood. Here we deeply profiled the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Res Sq
Päätekijät: Alter, Galit, Gorman, Matthew, Patel, Nita, Guebre-Xabier, Mimi, Zhu, Alex, Atyeo, Caroline, Pullen, Krista, Loos, Carolin, Goez-Gazi, Yenny, Carrion, Ricardo, Tian, Jing-Hui, Yuan, Dansu, Bowman, Kathryn, Zhou, Bin, Maciejewski, Sonia, McGrath, Marisa, Logue, James, Frieman, Matthew, Montefiori, David, Schendel, Sharon, Saphire, Erica Ollmann, Lauffenburger, Douglas, Greene, Ann, Portnoff, Alyse, Massare, Michael, Ellingsworth, Larry, Glenn, Gregory, Smith, Gale, Mann, Colin, Amanat, Fatima, Krammer, Florian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Journal Experts 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899467/
https://ncbi.nlm.nih.gov/pubmed/33619473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-200342/v1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia